Homepage

Intuitive Surgical, Inc.

ISRG NASDAQ Categories PDF
Healthcare · Medical - Instruments & Supplies · United States · Updated May 11, 12:48pm
$419.84
Price
$148.7B
Market Cap
15,638
Employees
1.51
Beta
David J. Rosa
CEO
Business Description

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Business History
Price Overview
Last updated: May 11, 2026 12:48pm (just now)
$419.85
-30.21 (-6.71%)
Day Range
$419.68 – $448.75
52-Week Range
$419.68 – $603.88
50-Day MA
$470.10
200-Day MA
$498.64
Volume
1,803,617.15
Analyst Price Targets
Low $525.00
Consensus $622.60
High $750.00
(94 analysts)
Share Structure
Outstanding 354,163,000.00
Float 351,967,032.00
Free Float 99.4%
High free float — 99.4% of shares trade freely, ~0.6% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
50.02
Stock Price: $419.84
EPS (Diluted): 8.00
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
11.34
Stock Price: $419.84
Total Equity: $17.82B
Shares: 362,700,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
39.02
Market Cap: $148.69B
Total Debt: $170.90M
Cash: $3.37B
EBITDA: $3.62B
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$199.1B
Market Cap: $148.69B
Total Debt: $170.90M
Cash: $3.37B
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
66.0%
Gross Profit: $6.64B
Revenue: $10.06B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
29.3%
Operating Income: $2.95B
Revenue: $10.06B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
28.4%
Net Income: $2.86B
Revenue: $10.06B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
17.0%
Net Income: $2.86B
Total Equity: $17.82B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
16.5%
Operating Income: $2.95B
Tax Rate: 13.1%
Equity: $17.82B
Total Debt: $170.90M
Cash: $3.37B
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
4.87
Current Assets: $9.78B
Current Liabilities: $2.01B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.01
Short-Term Debt: $39.00M
Long-Term Debt: $131.90M
Total Debt: $170.90M
Total Equity: $17.82B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$27.75
Revenue: $10.06B
Shares: 362,700,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$49.14
Total Equity: $17.82B
Shares: 362,700,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$6.87
Operating CF: $3.03B
CapEx: -$539.80M
Shares: 362,700,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $419.84
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $2.86B
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares ISRG against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $5.7B $6.2B $7.1B $8.4B $10.1B
Cost of Revenue $1.8B $2.0B $2.4B $2.7B $3.4B
Gross Profit $4.0B $4.2B $4.7B $5.6B $6.6B
Operating Expenses $2.1B $2.6B $3.0B $3.3B $3.7B
Operating Income $1.8B $1.6B $1.8B $2.3B $2.9B
Net Income $1.7B $1.3B $1.8B $2.3B $2.9B
EBITDA $2.1B $1.9B $2.2B $2.8B $3.6B
EPS $4.79 $3.72 $5.12 $6.54 $8.00
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $1.3B $1.6B $2.8B $2.0B $3.4B
Total Current Assets $5.8B $6.3B $7.9B $7.1B $9.8B
Total Assets $13.6B $13.0B $15.4B $18.8B $20.6B
Current Liabilities $1.1B $1.4B $1.7B $1.7B $2.0B
Long-Term Debt $0 $0 $0 $0 $131.9M
Total Liabilities $1.6B $1.9B $2.0B $2.3B $2.7B
Total Equity $12.0B $11.0B $13.3B $16.4B $17.8B
Retained Earnings $4.8B $3.5B $4.7B $6.8B $7.0B
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $2.1B $1.5B $1.8B $2.4B $3.0B
Capital Expenditure -$353.5M -$532.4M -$1.1B -$1.1B -$539.8M
Free Cash Flow $1.7B $958.4M $749.6M $1.3B $2.5B
Acquisitions (net) -$8.7M -$12.8M -$8.9M -$1.0M -$13.9M
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 -$2.6B -$416.3M $0 -$2.3B
Net Change in Cash -$332.5M $294.7M $1.2B -$707.7M $1.3B
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $13.3B
$12.8B – $13.6B
 $15.1B
$15.0B – $15.1B
 $17.2B
$16.7B – $18.1B
 $19.0B
$18.5B – $20.0B
EBITDA $4.5B
$4.3B – $4.6B
 $5.1B
$5.1B – $5.1B
 $5.8B
$5.6B – $6.1B
 $6.4B
$6.2B – $6.7B
Net Income $4.3B
$4.1B – $4.4B
 $4.3B
$4.2B – $5.3B
 $5.6B
$5.4B – $6.0B
 $6.1B
$5.9B – $6.5B
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +9.0% +14.5% +17.2% +20.5%
Gross Profit Growth +6.0% +12.7% +19.1% +17.9%
Operating Income Growth -13.4% +12.0% +32.9% +25.4%
Net Income Growth -22.4% +36.0% +29.2% +23.0%
EBITDA Growth -8.8% +11.6% +29.6% +28.9%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-04-30 GUTHART GARY S A-Award 554.00 $0.00 $0
2026-04-30 Reed Monica P M-Exempt 531.00 $0.00 $0
2026-04-30 Reed Monica P A-Award 554.00 $0.00 $0
2026-04-30 Reed Monica P M-Exempt 531.00 $0.00 $0
2026-04-30 NACHTSHEIM JAMI K M-Exempt 531.00 $0.00 $0
2026-04-30 NACHTSHEIM JAMI K A-Award 554.00 $0.00 $0
2026-04-30 NACHTSHEIM JAMI K M-Exempt 531.00 $0.00 $0
2026-04-30 Leonard Keith R M-Exempt 531.00 $0.00 $0
2026-04-30 Leonard Keith R A-Award 554.00 $0.00 $0
2026-04-30 Leonard Keith R M-Exempt 531.00 $0.00 $0
2026-04-30 Ladd Amy L M-Exempt 531.00 $0.00 $0
2026-04-30 Ladd Amy L A-Award 554.00 $0.00 $0
2026-04-30 Ladd Amy L M-Exempt 531.00 $0.00 $0
2026-04-30 Kolli Sreelakshmi M-Exempt 531.00 $0.00 $0
2026-04-30 Kolli Sreelakshmi A-Award 554.00 $0.00 $0
2026-04-30 Kolli Sreelakshmi M-Exempt 531.00 $0.00 $0
2026-04-30 Johnson Amal M M-Exempt 531.00 $0.00 $0
2026-04-30 Johnson Amal M M-Exempt 531.00 $0.00 $0
2026-04-30 CHEW LEWIS M-Exempt 531.00 $0.00 $0
2026-04-30 CHEW LEWIS A-Award 554.00 $0.00 $0
Community AI Feedback
Sign in to Contribute
No community reviews yet for ISRG. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27